Latest news & updates

Related information

This page shows the last 20 updates that have been made to the TGA website and includes product recalls, alerts and media releases/statements issued by the TGA in recent weeks.

The TGA also has a number of email lists to which you can subscribe to receive updates by email.

11 May 2012
PIP breast implants - TGA update
Updated information on safety concerns with PIP breast implants

10 May 2012
ANZTPA Update email list
Email subscription service notifying of news & updates related to ANZTPA or its business to business projects

10 May 2012
Improved search facilities from the eBS website
The TGA has launched an improved interface for the publicly accessible e-Business Services (eBS) website

9 May 2012
Draft compositional guideline: Magnesium citrate - dibasic tetrahydrate
Draft compositional guideine for magnesium citrate dibasic tetrahydrate. Closing date: 22 June 2012

4 May 2012
PIP breast implants - TGA update
Updated information on safety concerns with PIP breast implants

4 May 2012
Orphan drugs
Added ivacaftor to the list of designated orphan drugs

4 May 2012
Proposed advisory statements for medicines - fexofenadine and loperamide
The TGA is seeking comments from interested parties on the proposed advisory statements for fexofenadine and loperamide. Closing date: 4 June 2012

2 May 2012
Prominent Scientist and Regulator appointed new Head of TGA
Dr John Skerritt has been appointed the new national manager of the TGA

30 April 2012
Prescription medicine BPR update newsletter, April 2012
April 2012 issue of the Prescription Medicines Business Process Review newsletter

30 April 2012
Labelling and packaging review
Update regarding the labelling and packaging review

27 April 2012
Consumer questions & answers - PIP breast implants
Updated questions and answers for consumers about breast implants

27 April 2012
PIP breast implants - TGA update
Updated information on safety concerns with PIP breast implants

26 April 2012
Public submissions on scheduling matters referred to ACCS#4 and ACMS#5 (February 2012)
Additional submissions on scheduling matters for ACCS & ACMS February 2012 meetings

26 April 2012
Reasons for scheduling delegates' interim decisions & invitation for further comment, April 2012
Interim decisions & reasons for scheduling decisions and invitation for further submissions. Closing date: 10 May 2012

26 April 2012
The Poisons Standard (the SUSMP)
Added SUSMP No. 3 publication information & order form

26 April 2012
Invitation for public comment - ACMS and ACCS meetings, June 2012
Notice inviting public submissions under Regulation 42ZCZK of the Therapeutic Goods Regulations 1990. Closing date: 25 May 2012

26 April 2012
Scheduling news
Updates and news about scheduling medicines and poisons

23 April 2012
Consultation document on levels and kinds of evidence to support indications and claims for listed medicines - feedback invited
The TGA is seeking comment from interested parties on the draft of the document 'Evidence Required to Support Indications for Listed Medicines (excluding sunscreens and disinfectants)'

Web page last updated: Monday, 5 December 2011

URL: http://www.tga.gov.au/newsroom/news-latest.htm